INNOHEART
Innoheart is Asia's first state of art pre-clinical CRO specializing in the evaluation of medical devices. Its services include planning and execution of full GLP compliant in-life study protocols, utilizing various imaging modalities such as angiography, digital subtraction angiography, intravascular ultrasound and Optical Coherence Tomography. Innoheart has also a comprehensive onsite histology suite offering full plastic embedding and sectioning of metal/alloy implants. More details can be found at www.innoheart.com
INNOHEART
Industry:
Health Care Medical
Founded:
2006-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.innoheart.com
Total Employee:
11+
Status:
Active
Contact:
+65 97363220
Email Addresses:
[email protected]
Technology used in webpage:
GoDaddy DNS ASP.NET IIS GoDaddy Email IIS 6 Google Calendar Vodien
Similar Organizations
sanokinen
sanokinen is a hospital that offers health care and medical services.
Key Employee Changes
| Date | New article |
|---|---|
| 2020-08-06 | InnovHeart Appoints J. Brent Ratz as Chief Executive Officer and Member of the Board |
Official Site Inspections
http://www.innoheart.com Semrush global rank: 7.81 M Semrush visits lastest month: 437
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Innoheart"
InnovHeart - Crunchbase Company Profile & Funding
InnovHeart is a medical equipment manufacturing company. They develop transcatheter mitral valve replacement systems. They bring patients a novel therapeutic system suitable to replace …See details»
InnovHeart - LinkedIn
InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease.See details»
Org Chart InnovHeart - The Official Board
The org chart of InnovHeart contains its 7 main executives including David Wilson.See details»
InnovHeart 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for InnovHeart. Use the PitchBook Platform to explore the full profile.See details»
InnovHeart - Craft
InnovHeart is a medical device company focusing on mitral valve disease. It offers transcatheter mitral valve replacement (TMVR) systems for heart valve therapy. In addition, the company …See details»
INNOVHEART - Overview, News & Similar companies
May 30, 2019 View INNOVHEART (www.innovheart.com) location in Lombardy, Italy , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
InnovHeart - INDACO
InnovHeart is an Italian innovative PMI, with branches in USA, developing an innovative Transcatheter Mitral Valve Replacement (TMVR) system to treat patients suffering from mitral valve disease. Founded in 2015 by Giovanni …See details»
Who We Are - InnovHeart
InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease. The company is currently in clinical trials testing its …See details»
InnovHeart | Panakès Partners
InnovHeart is a highly innovative clinical stage Italian start-up founded in 2015 that is developing Saturn, a novel Transcatheter Mitral Valve Replacement (TMVR) technology for the treatment …See details»
InnovHeart - Contacts, Employees, Board Members, Advisors
InnovHeart is a developer of transcatheter mitral valve replacement systems to treat patients suffering from mitral valve disease.See details»
InnovHeart - EU-Startups
InnovHeart s.r.l develops Transcatheter Mitral Valve Replacement systems (TMVR) to treat patients suffering from mitral valve disease. The Company is in late preclinical development of …See details»
InnovHeart, the MedTech startup has concluded a Series B round …
The innovation offered by InnovHeart can aim to represent the best-in-class Mitral Regurgitation treatment device - on a global scale. In its most severe form, the pathology affects more than 4 …See details»
MedTech Strategist - InnovHeart: Multifunctional Mitral Valve ...
Oct 13, 2023 ARTICLE SUMMARY: In transcatheter mitral valve replacement, InnovHeart aims to replicate surgical experience, including ease of delivery and the ability to fit more patients.See details»
Transcatheter Mitral Valve Replacement Company InnovHeart …
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announced today the closing of a €20 million round of …See details»
Innoheart - Updates, News, Events, Signals & Triggers - Crunchbase
Innoheart is Asia's first state of art pre-clinical CRO specializing in the evaluation of medical devices.See details»
InnovHeart raises $55 million in Series C financing to further …
Jan 27, 2022 InnovHeart and Grand Pharmaceutical Group Enter Into an Exclusive License Agreement to Develop and Commercialize the Saturn TMVR Device in Greater China Milan, …See details»
InnovHeart - Funding, Financials, Valuation & Investors
InnovHeart is a developer of transcatheter mitral valve replacement systems to treat patients suffering from mitral valve disease.See details»
InnovHeart - Updates, News, Events, Signals & Triggers
InnovHeart is a developer of transcatheter mitral valve replacement systems to treat patients suffering from mitral valve disease.See details»
Culture, health awareness are key to reducing heart disease …
3 days ago Research Highlights: Native American tribal members identified five priorities to improve awareness of and access to care for heart disease: heart health education; cultural …See details»
First-In-Human Trans-Septal Implantation of Saturn Mitral
We are pleased to announce the first trans-septal clinical trial implant with our proprietary Saturn Transcatheter Mitral Valve. Excellent hemodynamic results are reported for the patient, a 79 …See details»